Cirius Therapeutics commences enrolment and dosing for Phase 2 study of CIR-0602K in type 1 diabetes
Bayer completes acquisition of Perfuse Therapeutics to strengthen ophthalmology pipeline
Sciwind Biosciences reports positive study data on ecnoglutide versus semaglutide
Tandem Diabetes Care receives CE mark for expanded automated insulin delivery indications in Europe
Lupin's Ranluspec (ranibizumab) injection receives US FDA approval
MiniMed expands Abbott partnership for dual glucose-ketone diabetes sensors
Samsung Bioepis launches OPUVIZ across Europe for ophthalmic conditions
Hims & Hers expands GLP-1 offering in Canada with generic semaglutide
Bayer's KERENDIA receives FDA priority review for type 1 diabetes and kidney disease treatment
Dexcom launches Dexcom Flex CGM system for Type 2 diabetes patients in Germany
Apotex announces commercial launch of Apo-Semaglutide Injection in Canada
Bayer to acquire Perfuse Therapeutics in USD2.45bn deal to expand ophthalmology pipeline